Business
OTC Markets Group Welcomes New OTCQB Companies – August 8
OTC Markets Group Welcomes New OTCQB Companies – August 8.
About this update from Novaccess Global Inc.
[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, announced the following companies are approved for trading on the OTCQB Venture Market:Active Energy Group Plc (LSE: AEG; OTCQB: ATGVF) Active Energy Group plc is a London listed (AIM: AEG) renewable energy company focused on the production and development of next generation biomass products that have the potential to transform traditional coal fired power and heavy industries and the existing renewable biomass industry. AEG has developed a proprietary technology platform which transforms waste biomass material into high-value renewable fuels. Its patented product CoalSwitch is a leading drop-in biomass renewable fuel that can be co-fired with coal, completely replace coal as an alternative feedstock without requiring significant plant modifications or wholly replace existing biomass feedstock resources . Active Energy Group's immediate strategic focus is the production and commercialization of CoalSwitch. CoalSwitch is a registered trademark belonging to Active Energy Group plc.Kesselrun Resources Ltd. (TSX-V: KES; OTCQB: KSSRF) Kesselrun Resources Ltd. is a Thunder Bay, Ontario-based mineral exploration company focused on growth through property acquisitions and discoveries. Kesselrun's management team possesses strong geological and exploration experience with particular expertise in Northwest Ontario.NovAccess Global Inc. (OTCQB: XSNX) NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. NovAccess Global are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through their advisory board they have experience successfully executing clinical trials, bringing products to market and increasing the market size of products. Sigyn Therapeutics Inc. (OTCQB: SIGY) Sigyn Therapeutics, Inc, is a development-stage therapeutic technology company headquartered in San Diego, California USA. Their focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Si...